86 related articles for article (PubMed ID: 17433261)
1. Bone morphogenetic protein-7 and interferon-alpha synergistically suppress hepatitis C virus replicon.
Sakamoto N; Yoshimura M; Kimura T; Toyama K; Sekine-Osajima Y; Watanabe M; Muramatsu M
Biochem Biophys Res Commun; 2007 Jun; 357(2):467-73. PubMed ID: 17433261
[TBL] [Abstract][Full Text] [Related]
2. Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication.
Itsui Y; Sakamoto N; Kurosaki M; Kanazawa N; Tanabe Y; Koyama T; Takeda Y; Nakagawa M; Kakinuma S; Sekine Y; Maekawa S; Enomoto N; Watanabe M
J Viral Hepat; 2006 Oct; 13(10):690-700. PubMed ID: 16970601
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.
Okuse C; Rinaudo JA; Farrar K; Wells F; Korba BE
Antiviral Res; 2005 Jan; 65(1):23-34. PubMed ID: 15652968
[TBL] [Abstract][Full Text] [Related]
4. [Investigating the inhibitory effects of interferon-alpha on the replication of hepatitis C virus replicon].
Jia YT; Wei L; Jiang D; Cong X; Fei R
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2065-9. PubMed ID: 16313804
[TBL] [Abstract][Full Text] [Related]
5. Combination of a hepatitis C virus NS3-NS4A protease inhibitor and alpha interferon synergistically inhibits viral RNA replication and facilitates viral RNA clearance in replicon cells.
Lin K; Kwong AD; Lin C
Antimicrob Agents Chemother; 2004 Dec; 48(12):4784-92. PubMed ID: 15561857
[TBL] [Abstract][Full Text] [Related]
6. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.
Jia Y; Wei L; Jiang D; Wang J; Cong X; Fei R
J Gastroenterol Hepatol; 2007 Aug; 22(8):1278-85. PubMed ID: 17565587
[TBL] [Abstract][Full Text] [Related]
7. [The direct antiviral effect of interferon-gamma on hepatitis C virus replicon].
Jia YT; Wei L; Jiang D; Cong X; Fei R
Zhonghua Gan Zang Bing Za Zhi; 2006 Jan; 14(1):7-10. PubMed ID: 16420756
[TBL] [Abstract][Full Text] [Related]
8. Suppression of hepatitis C virus replicon by TGF-beta.
Murata T; Ohshima T; Yamaji M; Hosaka M; Miyanari Y; Hijikata M; Shimotohno K
Virology; 2005 Jan; 331(2):407-17. PubMed ID: 15629783
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of intracellular hepatitis C virus replication by nelfinavir and synergistic effect with interferon-alpha.
Toma S; Yamashiro T; Arakaki S; Shiroma J; Maeshiro T; Hibiya K; Sakamoto N; Kinjo F; Tateyama M; Fujita J
J Viral Hepat; 2009 Jul; 16(7):506-12. PubMed ID: 19302339
[TBL] [Abstract][Full Text] [Related]
10. New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1.
Taylor DR; Puig M; Darnell ME; Mihalik K; Feinstone SM
J Virol; 2005 May; 79(10):6291-8. PubMed ID: 15858013
[TBL] [Abstract][Full Text] [Related]
11. Interferon-alpha and ribavirin resistance of Huh7 cells transfected with HCV subgenomic replicon.
Aus dem Siepen M; Oniangue-Ndza C; Wiese M; Ross S; Roggendorf M; Viazov S
Virus Res; 2007 Apr; 125(1):109-13. PubMed ID: 17254660
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines.
Zhang T; Lin RT; Li Y; Douglas SD; Maxcey C; Ho C; Lai JP; Wang YJ; Wan Q; Ho WZ
Hepatology; 2005 Oct; 42(4):819-27. PubMed ID: 16175599
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of the interferon alpha response against hepatitis C virus replicons.
Guo JT; Sohn JA; Zhu Q; Seeger C
Virology; 2004 Jul; 325(1):71-81. PubMed ID: 15231387
[TBL] [Abstract][Full Text] [Related]
14. Alcohol potentiates hepatitis C virus replicon expression.
Zhang T; Li Y; Lai JP; Douglas SD; Metzger DS; O'Brien CP; Ho WZ
Hepatology; 2003 Jul; 38(1):57-65. PubMed ID: 12829987
[TBL] [Abstract][Full Text] [Related]
15. Targeting lipid metabolism in the treatment of hepatitis C virus infection.
Amemiya F; Maekawa S; Itakura Y; Kanayama A; Matsui A; Takano S; Yamaguchi T; Itakura J; Kitamura T; Inoue T; Sakamoto M; Yamauchi K; Okada S; Yamashita A; Sakamoto N; Itoh M; Enomoto N
J Infect Dis; 2008 Feb; 197(3):361-70. PubMed ID: 18248300
[TBL] [Abstract][Full Text] [Related]
16. HCV structural proteins interfere with interferon-alpha Jak/STAT signalling pathway.
Luquin E; Larrea E; Civeira MP; Prieto J; Aldabe R
Antiviral Res; 2007 Nov; 76(2):194-7. PubMed ID: 17675168
[TBL] [Abstract][Full Text] [Related]
17. The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro.
Paeshuyse J; Kaul A; De Clercq E; Rosenwirth B; Dumont JM; Scalfaro P; Bartenschlager R; Neyts J
Hepatology; 2006 Apr; 43(4):761-70. PubMed ID: 16557546
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of hepatitis C virus replication by human T cell leukemia virus type I-encoded Tax protein.
Zhang J; Yamada O; Kawagishi K; Yoshida H; Araki H; Yamaoka S; Hattori T; Shimotohno K
Virology; 2007 Dec; 369(1):198-205. PubMed ID: 17765943
[TBL] [Abstract][Full Text] [Related]
19. Oncostatin M synergistically inhibits HCV RNA replication in combination with interferon-alpha.
Ikeda M; Mori K; Ariumi Y; Dansako H; Kato N
FEBS Lett; 2009 May; 583(9):1434-8. PubMed ID: 19332062
[TBL] [Abstract][Full Text] [Related]
20. Regulation of hepatitis C virus replication by interferon regulatory factor 1.
Kanazawa N; Kurosaki M; Sakamoto N; Enomoto N; Itsui Y; Yamashiro T; Tanabe Y; Maekawa S; Nakagawa M; Chen CH; Kakinuma S; Oshima S; Nakamura T; Kato T; Wakita T; Watanabe M
J Virol; 2004 Sep; 78(18):9713-20. PubMed ID: 15331704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
